- Home
- FLS vs QGEN Comparison
FLS vs QGEN Comparison
Compare FLS & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLS
- QGEN
- Stock Information
- Founded
- FLS 1790
- QGEN 1986
- Country
- FLS United States
- QGEN Netherlands
- Employees
- FLS N/A
- QGEN N/A
- Industry
- FLS Fluid Controls
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLS Industrials
- QGEN Health Care
- Exchange
- FLS Nasdaq
- QGEN Nasdaq
- Market Cap
- FLS 8.3B
- QGEN 9.1B
- IPO Year
- FLS N/A
- QGEN 1996
- Fundamental
- Price
- FLS $53.29
- QGEN $47.90
- Analyst Decision
- FLS Strong Buy
- QGEN Buy
- Analyst Count
- FLS 9
- QGEN 9
- Target Price
- FLS $64.11
- QGEN $50.79
- AVG Volume (30 Days)
- FLS 3.4M
- QGEN 1.4M
- Earning Date
- FLS 07-28-2025
- QGEN 07-30-2025
- Dividend Yield
- FLS 1.81%
- QGEN 3.24%
- EPS Growth
- FLS 20.22
- QGEN N/A
- EPS
- FLS 2.14
- QGEN 0.42
- Revenue
- FLS $4,614,870,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- FLS $7.11
- QGEN $6.36
- Revenue Next Year
- FLS $3.67
- QGEN $6.18
- P/E Ratio
- FLS $21.70
- QGEN $110.70
- Revenue Growth
- FLS 4.23
- QGEN 3.31
- 52 Week Low
- FLS $37.34
- QGEN $37.63
- 52 Week High
- FLS $65.08
- QGEN $48.36
- Technical
- Relative Strength Index (RSI)
- FLS 64.87
- QGEN 71.53
- Support Level
- FLS $45.11
- QGEN $46.37
- Resistance Level
- FLS $47.63
- QGEN $46.83
- Average True Range (ATR)
- FLS 1.30
- QGEN 0.69
- MACD
- FLS 0.28
- QGEN -0.00
- Stochastic Oscillator
- FLS 97.82
- QGEN 89.25
About FLS Flowserve Corporation
Flowserve Corp is a manufacturer and aftermarket service provider of comprehensive flow control systems. It develops precision-engineered flow control equipment to monitor movement and protect customers' materials and processes. It offers an extensive range of pumps, valves, seals, and services for several industries, including oil and gas, chemical, power generation, and water management. In addition, Flowserve has a network of Quick Response Centers to provide aftermarket equipment services. The aftermarket services help customers with installation, diagnostics, repair, and retrofitting. Sales are roughly split across many regions, with North America and Europe contributing the majority of total revenue.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).